What is MYO's health score?

MYOMO, INC. (MYO) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MYO's estimated fair value?

Based on our 5-year discounted cash flow model, MYOMO, INC.'s estimated fair value is $1.73 per share, representing a 59.0% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MYO undervalued or overvalued?

Our model currently rates MYO as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MYO... Refresh in a moment for the full analysis.

MYOMO, INC. (MYO)

Healthcare Undervalued low mixed

$1.09

Updated: 2026-05-30

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

53 Mixed

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

35 Weak

Est. Fair Value $1.73

DCF Upside +59.0%

Sector Rank #351 of 6898

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.